The Role of Obesity in Type 2 Diabetes Mellitus-An Overview

被引:58
|
作者
Chandrasekaran, Preethi [1 ]
Weiskirchen, Ralf [2 ]
机构
[1] UT Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd ND10 504, Dallas, TX 75390 USA
[2] Univ Hosp Aachen, Rheinisch Westfalische TH RWTH, Inst Mol Pathobiochem Expt Gene Therapy & Clin Che, D-52074 Aachen, Germany
关键词
obesity; type; 2; diabetes; pathophysiology; incidence; prevalence; management; therapeutic approach; in vivo studies; clinical trials; IMPROVES INSULIN-RESISTANCE; ADIPOSE-TISSUE; OXIDATIVE STRESS; METABOLIC SYNDROME; WEIGHT MANAGEMENT; PEPTIDE-1; ANALOG; FAT ACCUMULATION; MOUSE MODEL; WHITE; OVERWEIGHT;
D O I
10.3390/ijms25031882
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity or excessive weight gain is identified as the most important and significant risk factor in the development and progression of type 2 diabetes mellitus (DM) in all age groups. It has reached pandemic dimensions, making the treatment of obesity crucial in the prevention and management of type 2 DM worldwide. Multiple clinical studies have demonstrated that moderate and sustained weight loss can improve blood glucose levels, insulin action and reduce the need for diabetic medications. A combined approach of diet, exercise and lifestyle modifications can successfully reduce obesity and subsequently ameliorate the ill effects and deadly complications of DM. This approach also helps largely in the prevention, control and remission of DM. Obesity and DM are chronic diseases that are increasing globally, requiring new approaches to manage and prevent diabetes in obese individuals. Therefore, it is essential to understand the mechanistic link between the two and design a comprehensive approach to increase life expectancy and improve the quality of life in patients with type 2 DM and obesity. This literature review provides explicit information on the clinical definitions of obesity and type 2 DM, the incidence and prevalence of type 2 DM in obese individuals, the indispensable role of obesity in the pathophysiology of type 2 DM and their mechanistic link. It also discusses clinical studies and outlines the recent management approaches for the treatment of these associated conditions. Additionally, in vivo studies on obesity and type 2 DM are discussed here as they pave the way for more rigorous development of therapeutic approaches.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
    Li, Wei-Dong
    Fu, Kun-Fa
    Li, Gui-Mei
    Lian, Yan-Shu
    Ren, Ai-Min
    Chen, Yun-Jue
    Xia, Jin-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9607 - 9613
  • [2] Type 2 diabetes mellitus-an autoimmune disease?
    Velloso, Licio A.
    Eizirik, Decio L.
    Cnop, Miriam
    NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (12) : 750 - 755
  • [3] Atorvastatin prevents type 2 diabetes mellitus-An experimental study
    Madhu, Venkata
    Aslam, Mohammad
    Galav, Vikas
    Bhattacharya, Swapan Kumar
    Jafri, Aiman Abbas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 728 : 135 - 140
  • [4] An Overview of Dietary Supplements on Obesity and Type 2 Diabetes: Efficacy and Mechanisms
    Liu, Xiaohong
    Zeng, Xin
    Liu, Wen
    Lu, Yanrong
    Cheng, Jingqiu
    Chen, Younan
    CURRENT DRUG METABOLISM, 2021, 22 (06) : 415 - 440
  • [5] Adipokines: Role in the pathophysiology and therapy of obesity and type 2 diabetes
    Fasshauer, Mathias
    Blueher, Matthias
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2009, 33 (01): : 1 - 6
  • [6] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Tai, Ningwen
    Wong, F. Susan
    Wen, Li
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2015, 16 (01) : 55 - 65
  • [7] Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
    Rasul, Sazan
    Wagner, Ludwig
    Kautzky-Willer, Alexandra
    ENDOCRINE, 2012, 42 (03) : 496 - 505
  • [8] Chrononutrition in type 2 diabetes mellitus and obesity: A narrative review
    Verde, Ludovica
    Di Lorenzo, Tonia
    Savastano, Silvia
    Colao, Annamaria
    Barrea, Luigi
    Muscogiuri, Giovanna
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [9] Tipping the Balance: the Pathophysiology of Obesity and Type 2 Diabetes Mellitus
    McKenney, Rachel L.
    Short, Daniel K.
    SURGICAL CLINICS OF NORTH AMERICA, 2011, 91 (06) : 1139 - +
  • [10] Ketogenic diets as treatment of obesity and type 2 diabetes mellitus
    Casanueva, Felipe F.
    Castellana, Marco
    Bellido, Diego
    Trimboli, Pierpaolo
    Castro, Ana, I
    Sajoux, Ignacio
    Rodriguez-Carnero, Gemma
    Gomez-Arbelaez, Diego
    Crujeiras, Ana B.
    Martinez-Olmos, Miguel A.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2020, 21 (03) : 381 - 397